Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve Increase in Authorised ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals has informed BSE that its Board of Directors will meet on Saturday, 7 February 2026 at 3:00 PM. The Board will consider increasing the company's authorised share capital and raising of funds. It will also finalise the date and notice for an Extraordinary General Meeting (EGM) to be held via video conferencing, and approve the appointment of a statutory auditor. Asston is a recently-listed small-cap pharma company that converted from private to public limited status.
The authorised capital hike and 'raising of funds' agenda suggest a possible equity dilution event for existing shareholders, though specifics are not yet disclosed. Shareholders should watch for the EGM outcome for details on the size, pricing, and structure of any fundraising.